Probiotic and Prebiotic Supplementation in Peritoneal Dialysis Patients (NCT07694791)
Impact of Synbiotic Supplementation in Peritoneal Dialysis Patients
🩺 Plain-English Summary (8th-Grade Level)
The goal of this clinical trial is to learn if synbiotics work to lower inflammation in adults with chronic kidney disease who are on peritoneal dialysis. Synbiotics are daily capsules that contain a mix of probiotics (good bacteria) and prebiotics (fiber that feeds good bacteria). The main questions it aims to answer are: Do synbiotics lower the level of inflammation markers in the blood? Do synbiotics improve the nutritional status of the participants? Do synbiotics lower the number of peritonitis (peritoneal infections) episodes? Researchers will compare synbiotics to a placebo to see if the treatment works. A placebo is a look-alike capsule that contains no active ingredients. Participants will: Take 1 capsule every day for 6 months Visit the clinic at the start, at 3 months, and at 6 months for blood tests and nutrition checkups
Who can join: Review the eligibility criteria below.
Location: Hospital Universitario Dr. José E. González, Centro Regional de Enfermedades Renales (CRER) — Monterrey, Nuevo León
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Hospital Universitario Dr. José E. González, Centro Regional de Enfermedades Renales (CRER) — Monterrey, Nuevo León
📞 Contact the Study Coordinator
Phone: 528182803788
Email: eguerrerog@uanl.edu.mx
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Chronic Kidney Disease (Stages 4 and 5)
- Kidney RISE: Randomized Integrated Supportive CarE Trial — Atlanta, Georgia
- Symptom Monitoring With Supported Feedback in Advanced Chronic Kidney Disease — Boston, Massachusetts
- Outcomes of Physiologic Insulin Resensitization (PIR) in Patients With Chronic Kidney Disease and Type 2 Diabetes Mellitus — Phoenix, Arizona
Explore by condition: All Chronic Kidney Disease (Stages 4 and 5) clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.